JP1695380S - - Google Patents

Info

Publication number
JP1695380S
JP1695380S JPD2020-23270F JP2020023270F JP1695380S JP 1695380 S JP1695380 S JP 1695380S JP 2020023270 F JP2020023270 F JP 2020023270F JP 1695380 S JP1695380 S JP 1695380S
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JPD2020-23270F
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JPD2020-23270F priority Critical patent/JP1695380S/ja
Priority to US29/780,617 priority patent/USD990537S1/en
Priority to TW110302165F priority patent/TWD217790S/zh
Application granted granted Critical
Publication of JP1695380S publication Critical patent/JP1695380S/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JPD2020-23270F 2020-10-28 2020-10-28 Active JP1695380S (enExample)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JPD2020-23270F JP1695380S (enExample) 2020-10-28 2020-10-28
US29/780,617 USD990537S1 (en) 2020-10-28 2021-04-26 Coupler for actuator
TW110302165F TWD217790S (zh) 2020-10-28 2021-04-27 致動器用連結器之部分

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JPD2020-23270F JP1695380S (enExample) 2020-10-28 2020-10-28

Publications (1)

Publication Number Publication Date
JP1695380S true JP1695380S (enExample) 2021-09-21

Family

ID=77767822

Family Applications (1)

Application Number Title Priority Date Filing Date
JPD2020-23270F Active JP1695380S (enExample) 2020-10-28 2020-10-28

Country Status (3)

Country Link
US (1) USD990537S1 (enExample)
JP (1) JP1695380S (enExample)
TW (1) TWD217790S (enExample)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD442981S1 (en) * 2000-03-17 2001-05-29 Steiner Company, Inc. Aerosol actuation unit
CA2435517A1 (en) * 2001-01-26 2002-08-08 Tol-O-Matic, Inc. Electric actuator
US6748967B1 (en) * 2002-03-21 2004-06-15 Uniplex Corporation Coupler for joining actuator and valve
USD513307S1 (en) 2004-08-25 2005-12-27 Fujikin Incorporated Joint member for fluid control apparatus
US7408848B2 (en) * 2004-12-28 2008-08-05 Industrial Technology Research Institute Objective lens actuator
USD551739S1 (en) * 2005-05-25 2007-09-25 Asmo Co., Ltd. Actuator for automotive air conditioner
EP2893235A4 (en) * 2012-09-07 2016-04-20 Creare Inc ACTUATOR FOR AN INLINE VACUUM COVERED CONTROL VALVE FOR CRYOGENIC LIQUIDS
USD720833S1 (en) 2014-02-21 2015-01-06 Freefly Systems, Inc. Quick release assembly
USD748759S1 (en) 2014-07-25 2016-02-02 Guide Valve Limited Valve flange with bleed port
USD754819S1 (en) 2014-11-04 2016-04-26 Valbia S.R.L. Valve with actuator
USD800870S1 (en) 2015-06-19 2017-10-24 Clarke Industrial Engineering, Inc. Valve housing
JP1610448S (enExample) * 2017-08-31 2018-08-06
JP1671808S (enExample) 2020-04-30 2020-11-02
JP1671807S (enExample) 2020-04-30 2020-11-02

Also Published As

Publication number Publication date
USD990537S1 (en) 2023-06-27
TWD217790S (zh) 2022-03-21

Similar Documents

Publication Publication Date Title
BR102021007058A2 (enExample)
BR102020022030A2 (enExample)
JP1671808S (enExample)
AR134288A1 (es) UN PÉPTIDO CÍCLICO PARA ATRAPAR LA INTERLEUCINA-1b
AR134282A1 (es) Compuestos y composiciones farmacéuticas que degradan el regulador de la subfamilia a de la cromatina dependiente de actina asociado a la matriz relacionado con swi / snf
AR134271A1 (es) Variantes de cnp, conjugados y formulaciones de los mismos
AR134276A1 (es) ANTICUERPOS ANTI-MIGIS-a Y MÉTODOS DE USO DE ESTOS
AR134275A1 (es) Anticuerpos cd24
AR134266A1 (es) Métodos para tratar el cáncer utilizando compuestos que inhiben la pkmyt1
AR134264A1 (es) Correctores farmacológicos de rodopsina y sus usos
AR134263A1 (es) Tratamiento de covid persistente con composición de vesículas extracelulares
AR134262A1 (es) Formulación líquida de agente biológico en almacenamiento estable
AR134259A1 (es) Compuestos de pirimidina bicíclicos, métodos y usos de estos
AR134258A1 (es) Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina
AR134257A1 (es) Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina
AR134219A1 (es) Derivados de (piperidin-4-il)-1,5-naftiridina y (piperidin-4-il)quinolina sustituidos y usos de los mismos
AR134214A1 (es) Redireccionamiento de cápsides de aav para dirigirlas al sistema nervioso central
AR134215A1 (es) Compuestos de tiazol y métodos de uso
AR134203A1 (es) Compuestos para la degradación de braf mutante
AR134200A1 (es) Combinaciones de herbicida / protector a base de herbicidas de la clase de las amidas de ácido n-(1,3,4-oxadiazol-2-il)fenilcarboxílico quirales y sus sales
AR134206A1 (es) Degradantes y usos de los mismos
AR134198A1 (es) Compuestos de proteasa 1 de procesamiento específico de ubiquitina (usp1)
AR134193A1 (es) Métodos para tratar tumores tenosinoviales de células gigantes
AR134194A1 (es) Nuevos moduladores de nitrato, amonio y potasio en plantas y métodos para usarlos
AR134180A1 (es) Péptidos inmunogénicos de magea1, proteínas de unión que reconocen los péptidos inmunogénicos de magea1 y usos de los mismos